Skip to main content
PLOS One logoLink to PLOS One
. 2025 Aug 21;20(8):e0330753. doi: 10.1371/journal.pone.0330753

Prevalence of hypertension and its associated factors among government employees in Doti district of Nepal

Ramesh Malashi 1, Sunita Sharma 1,*, Srijana Adhikari 1, Chitra Raj Sharma 2, Arun Kumar Joshi 3, Buna Bhandari 1,4
Editor: Chhabi Lal Ranabhat5
PMCID: PMC12370075  PMID: 40839587

Abstract

Introduction

Hypertension is a significant risk factor for cardiovascular diseases (CVDs), which remains the leading causes of morbidity and mortality globally, with a disproportionate impact on low and middle income countries. While hypertension is prevalent across various populations, government employees are particularly susceptible due to high stress levels, sedentary lifestyles, and work-related pressures. Therefore, this study was undertaken to assess the prevalence of hypertension and its associated risk factors among government employees in the Doti district of Nepal.

Methods

A cross-sectional study was carried out among 195 government employees in Dipayal Silgadhi Municipality of Doti district of Sudurpashchim province of Nepal. The data was collected through face-to-face interviews using Simple Random Sampling (SRS) technique and analysed using SPSS v25. The structured questionnaire adopted from the WHO STEPS survey tool was used for data collection. Bivariate and multivariate logistic regression model was used to assess the factors associated with hypertension.

Results

The prevalence of hypertension among government employee was 36.4%% ± 5.6%. Participants with age group 30–40 years [Adjusted Odd’s Ratio (AOR) 14.4, 95% Confidence Interval (CI) (1.6, 127.7)], 40–50 years [AOR 13.7, 95% CI (1.04, 180.3)] and work experience (20–30 years) [AOR 6.67, 95% CI(1.23, 35.9), and drinking alcohol [AOR 0.35, 95% CI (0.17, 0.72)] were found to be statistically significant with hypertension.

Conclusion

The study revealed the high prevalence of hypertension among government employees; significantly associated with risk factors like age group 30–50 years, work experience and alcohol consumption, indicating an alarming public health concern. These results highlight the pressing need for focused interventions to reduce the risk of hypertension and its related problems among government employees, such as lifestyle changes, workplace health programs, and routine health screenings.

Introduction

Hypertension is a leading modifiable risk factor for cardiovascular diseases (CVDs) and premature mortality worldwide. Between 1990 and 2019, global deaths from CVDs increased steadily from 12.1 million to 18.6 million respectively [1]. The prevalence of hypertension among adults is higher in Low Middle Income Countries (LMICs) (31.5%, 1.04 billion people) than in High-Income Countries (28.5%, 349 million people) [2]. The rising prevalence of hypertension, coupled with low medication adherence, poor blood pressure control, and limited knowledge about the condition, presents significant challenges, particularly in low- and middle-income countries (LMICs) [2].

Hypertension has emerged as a major global health challenge, with the 2019 Global Burden of Disease (GBD) study highlighting it as a leading contributor to disability-adjusted life years (DALYs), largely because of its connection with serious conditions like ischemic heart disease, stroke, and chronic kidney disease [3]. In Nepal, a systematic review and meta-analysis revealed that 28.52% of individuals were affected by hypertension, with key risk factors including body mass index (BMI), educational status, tobacco use, alcohol consumption, and physical activity [4]. Similarly, a study conducted in Pokhara found a staggering 66.2% age-adjusted prevalence of hypertension, with alcohol use, obesity, and a family history of hypertension being significant contributing factors [5]. These statistics paint a stark picture of the growing hypertension crisis and underscore the need for urgent action to address this silent yet dangerous epidemic.

According to various epidemiological studies, stress, obesity, and a sedentary lifestyle are important risk factors for hypertension [6,7]. Government employees are the working population who are often exposed to sedentary lifestyles, prolonged work-related stress, irregular eating habits, and limited physical activity due to desk-bound job responsibilities. These occupational risk factors may increase their vulnerability to developing non-communicable diseases such as hypertension [6]. A study conducted among civil servants in South Africa reported the prevalence of hypertension was 24.5% among 546 participants, concluding that one in four civil servants is hypertensive [8]. Similarly, study conducted among bankers of Kathmandu reported the prevalence of hypertension of 11.3% and its significant association with gender, diabetes and physical inactivity [9].

While several studies have focused on the general population, there remains a significant knowledge gap regarding the prevalence of hypertension and its associated factors within specific groups, like data from government officials which forms the rationale behind this study. Doti district, one of the underprivileged rural and hilly areas of Nepal has insufficient health data, especially when it comes to non-communicable diseases like hypertension. Studying prevalence of hypertension among government employees in a rural setting like Doti district not only closes a significant evidence gap but also contributes to the development of targeted strategies for the prevention and management of hypertension in underprivileged areas of Nepal. Therefore, the primary objective of this study was to assess the prevalence of hypertension and its associated factors among government employees in Dipayal Silgadhi Municipality, Doti district, Nepal.

Materials and methods

Study design and setting

An analytical cross-sectional study was conducted at Dipayal Silgadhi Municipality of Doti District, one of the hilly districts of Far Western Province, Nepal. The district covers an area of 2025 square kilometers. The district has a population of 205683 and households of 36806 as per census 2022 AD [10].

Study population

The study population consisted of Government employees working in civil service, health service, and miscellaneous service within the administrative area of Dipayal Silgadhi Municipality of Doti district. Miscellaneous service includes other gazetted-level government employees falling outside administration or health like audit, foreign affairs, statistics, engineering, agricultural, and other services. Currently employed government staffs that were present during the data collection period were included in the study, while those who were on leave or absent were excluded.

Sample size

The total calculated sample size of 195 was determined using the statistical formula by Cochran for a finite population. The expected proportion (p) in population was based on National Demographic Health Survey (NDHS) of Nepal = 0.20, i.e., prevalence of hypertension among adult population [11] with a 95% confidence interval and a 5% absolute margin of error. Since the study population was limited to government employees in Doti district, the total number of government employees in Doti (N = 625).

Sample size (n) = n0 /{1+(n01)/N}

Hence,

n0= (1.96)2*0.2*0.8(0.05)2
= 245.86  246
= 245.86  246

Now,

required sample (n)= n0/{1+(n01)N}\]
= 246/{1+(2461)/625}
= 176.7  177

Considering 10% non- response rate, total required sample size = 177 + 18 = 195

Sampling technique

The probability sampling (simple random sampling) method was used in the study. A list of government offices was collected from the Municipality office of Dipayal Silgadhi Municipality and the District Administration Office (DAO) of Doti district. Then, a list of government employees was obtained from respective offices, and a sampling frame was prepared. The total number of Government employees within the Dipayal Silgadhi Municipality was 625. The required sample was selected by SRS technique using lottery method. The individual sample was informed about the objective, process, and written consent for the study was taken before data collection.

Data collection tools and technique

Data was collected from 5th December 2022–4th January 2023. It was collected through Face-to-face interviews using a standard structured questionnaire with the help of two trained enumerators (Health Assistants) after one day of orientation. Questionnaire was adopted from the STEP survey tools of WHO, which have been validated in Nepali by Nepal Health Research Council (NHRC) [12]. Total 210 participants were approached for data collection, among them 195 participants agreed to participate in the study with the response rate of 93%.

Blood pressure measurement

The Blood pressure of the participants was measured as per the guidelines provided by Centers for Disease Control and Prevention (CDC) 2021 [13] and measurement of blood pressure was done by using the Omran HBP-1300 upper arm automatic blood pressure monitor. As per the CDC guidelines, data was collected only after confirming that the participants had their last meal intake an hour before. Participants were further asked about their last smoking and alcohol consumption as it may also alter the blood pressure measurement. None of the participants reported non-consumption of smoking or alcohol before 30 minutes at the time of data collection.

Before the Blood Pressure measurement, participants were asked to sit comfortably in sitting position and then blood pressure was measured using Omran HBP-1300 upper arm automatic blood pressure monitor in the right arm. Three BP measurements were taken at three-minute intervals after participants rested for at least ten minutes. The average of the last two measurements was included in the study. Individuals were defined as hypertensive if their Systolic Blood Pressure (SBP) was 140 mmHg or higher and/or if their Diastolic Blood Pressure (DBP) was 90 mmHg or higher or if they were taking antihypertensive medication [14].

Pre-hypertension: SBP = 120–139 mmHg and/or DBP = 80–89 mmHg Stage 1 Hypertension: SBP = 140–159 mmHg and/or DBP = 90–99 mmHg Stage 2 Hypertension: SBP ≥ 160 mmHg and/or DBP ≥ 100 mmHg [14]. Data collection began on 5th December 2022 and was completed on 4th Jan 2023.

Independent Variables

Socio-demographic variables: Age, Sex, Marital status, Ethnicity, Religion, Family history of hypertension

Socio-economic variables: Education, Service, Income (personal)

Behavioural variables: Diet (Fruit, vegetables, salt), Physical activity, Tobacco use, Alcohol use

Validity and Reliability of the tools

The validated questionnaire used in STEP Survey (WHO) was used in the study. Content validity was ensured by developing the questionnaire according to the objectives of the study and study variables. Frequent consultation was done with the subject experts and research supervisors while developing the tools. Pretesting of questionnaire was done among 10% of similar sample and ambiguous words with vague terms were modified post pre-testing. For consistent and reliable information, one day orientation was provided to the enumerators for data collection and supervision was sought throughout the data collection process.

Data management and analysis

The collected data were checked manually to minimize the possible errors and the data were systematically coded and entered in Epi-Data 3.1. The entered data were exported to IBM-SPSS version 25 for further analysis.

Using univariate analysis, frequency and percentages of socio-demographic, behavioral and dependent variables were presented in a frequency table. Bivariate analysis was done to assess the factors associated with hypertension and p-values at a 95% level of confidence were reported. The multivariate analysis was done between independent and dependent variables which were found to be statistically significant in bivariate analysis. Multicollinearity was assessed using Variance Inflation Factor (VIF) diagnostics with a cutoff of 10 and the goodness of fit of the logistic regression model was assessed using the Hosmer–Lemeshow test.

Ethical considerations

Ethical approval was obtained from Institutional Review Committee (IRC), Institute of Medicine, Tribhuvan University [Ref.no.258(6–11)E22079/080]. Before data collection, approval was obtained from respective government offices. Written informed consent, after explanation about the study, was obtained from the study participants.

Results

Total 210 participants were approached for data collection: among them 195 participants agreed to participate in the study with the response rate of 93%. The mean ±SD age of participants was 38.76 ± 11.32 years and the age range of 20 years to 60 years. There were 71.8% male participants, followed by females (28.2%). 89.8% of participants were Brahmin/Chhetri followed by Dalit (5.1%) and Janajati (5.1%). About one third (33.3%) of them had bachelor and higher level of education and most of them (85.6%) were married. In addition, most of the participants (71.3%) were doing civil service, followed by health service (18.5%) and miscellaneous services (10.3%), as presented in Table 1.

Table 1. Socio-demographic characteristics of study participants (n = 195).

Variables Number Percentage
Age (in years)
Mean age 38.76 years, SD = 11.32 years
20–30 63 32.3
30–40 56 28.7
40–50 30 15.4
50–60 46 23.6
Sex
Male 140 71.8
Female 55 28.2
Ethnicity
Dalit 10 5.1
Janajati 10 5.1
Brahmin/Chhetri 175 89.8
Education
Less than primary level 27 13.8
Primary level completed 25 12.8
Secondary level completed 52 26.8
Intermediate level 26 13.3
Bachelor and higher level 65 33.3
Marital Status
Married 167 85.6
Unmarried 28 14.4
Service type
Civil service 139 71.3
Health service 36 18.4
Miscellaneous service 20 10.3

The prevalence of hypertension among government employee was found to be 36.4% ± 5.6% (95% confidence, with finite population correction) as presented in Table 2. The margin of error for sample size (n = 195) and total number of government employees in Doti (N = 625) with 95% Confidence Interval has been calculated as follows,

Table 2. Prevalence of Hypertension (n = 195).

Characteristics Number Percentage
Non-Hypertensive (<140/90 mm of Hg) 124 63.6
Hypertensive (≥140/90 mm of Hg) 71 36.4
  • Step 1: Standard Error (without FPC)

SE= p(1p)n= 0.364(10.364)195= 0.00118720.03447
  • Step 2: Finite Population Correction (FPC)

FPC= NnN1= 625195624= 430624= {0.688}0.8294
  • Step 3: Corrected Margin of Error (MoE)

MoE=z×SE×FPC=1.96×0.03447×0.8294=1.96×0.028590.05604
Margin of Error= 5.6%

Association of socio-demographic variables and hypertension

The table below shows the multivariate analysis of socio-demographic variables with hypertension. Age group of the participants and working experience were found statistically significant with hypertension in multivariate analysis. Participants in age group 30–40 years [AOR = 14.4 CI 1.6, 127.7] and 40–50 years [AOR = 13.7, CI (1.04, 180.3)] were found to be statistically significant. The result also revealed that the participants who had more than 20 years of working experience were statistically significant with hypertension as presented in Table 3.

Table 3. Association of socio-demographic variables with hypertension (n = 195).

COR p-value AOR p-value
Variables CI (95%) CI (95%)
Age group
 20–30 Ref
 30–40 0.02 (0.01, 0.09) 0.001* 14.4 (1.6, 127.7) 0.016*
 40–50 0.25 (0.11, 0.57) 0.001* 13.7 (1.04, 180.3) 0.046*
 50–60 0.73 (0.28, 1.89) 0.511 11.6 (0.73, 6.5) 0.082
Sex
 Female Ref
 Male 5.77 (2.4, 13.64) 0.001* 2.25 (0.79, 6.5) 0.130
Education
 Less than primary level Ref
 Primary level 0.62 (0.21, 1.88) 0.406 0.88 (0.23, 3.32) 0.860
 Secondary level 0.38 (0.15, 1.01) 0.052 0.82 (0.25, 2.62) 0.746
 Intermediate level 0.10 (0.03, 0.43) 0.002* 0.36 (0.06, 2.02) 0.249
 Bachelor or higher 0.5 (0.20, 1.24) 0.135 1.31 (0.39, 4.37) 0.654
Marital status
 Unmarried Ref
 Married 5.72 (1.66, 19.71) 0.006* 0.28 (0.02, 2.94) 0.292
Work experience (in years)
 Less than 10 Ref
 10–20 3.86 (1.47, 10.12) 0.006* 1.83 (0.55, 6.03) 0.319
 20–30 13.7 (5.7, 32.8) 0.001* 6.67 (1.23, 35.9) 0.027*
 30–40 12.3 (4.4, 34.5) 0.001* 6.09 (0.81, 45.9) 0.080

*Statistically significant association with hypertension.

While applying the multivariate analysis, the Hosmer and Lemeshow test was performed to test the goodness of fit. This test found the model to be fit (p = 0.345), which was greater than the cut-off point of value (p = 0.05). The coefficient of determinant (Nagelkerke R square) for the equation was 0.445, which explained that the independent variables explained about 45% of the change in the dependent variable.

Association of behavioral factors with hypertension

Upon multivariate regression analysis, ever drinker was statistically significant with hypertension [AOR 0.35, 95% CI (0.17, 0.72)] as presented in Table 4.

Table 4. Association of behavioral factors with hypertension (n = 195).

Variables Crude OR (CI 95%) p-value Adjusted OR (CI 95%) p-value
Ever smoking tobacco
 No Ref
 Yes 2.16 (1.19, 3.93) 0.011* 0.77 (0.38, 1.57) 0.486
Ever drinker
 No Ref
 Yes 3.18 (1.72, 5.91) 0.01* 0.35 (0.17, 0.72) 0.005*
Frequency of Smokeless tobacco consumption
 Less than 5 Ref
 5–10 1.01 (0.26, 3.92) 0.985 0.66(0.12, 3.64) 0.640
 10–15 3.25 (0.7, 15.07) 0.132 0.79 (0.10, 5.97) 0.820
 More than 15 5.57 (1.12, 27.5) 0.035* 2.31 (0.34, 15.7) 0.391
Frequency of drinking
 Occasionally Ref
 Daily 1.96 (0.53, 7.20) 0.309 1.32 (0.24, 7.29) 0.745
 Weekly 4.90 (1.19, 20.1) 0.027* 1.28 (0.20, 7.93) 0.787
 Once a month 3.27 (3.27, 19.3) 0.191 0.62 (0.04, 9.02) 0.731

*Statistically significant association with hypertension.

The Hosmer and Lemeshow test was used to test the goodness of fit, which found the model to be fit (p = 0.820). The coefficient of determinant (Nagelkerke R square) for the equation was 0.091, which explained that 9.1% of the change in the dependent variable was explained by the independent variables.

Discussion

The prevalence of hypertension among government employees in this study was found to be 36.4% (95% CI: 30.8%–42.0%) and the factors associated with hypertension were age group 30–50 years, work experience, and alcohol consumption.

Globally, hypertension affects approximately one-third of the adults, about 31.1% as estimated by a global systematic review, reflecting a growing burden of cardiovascular disease worldwide [2]. The prevalence of hypertension is disproportionately higher in low- and middle-income countries (LMICs) at 31.5%, compared to 28.5% in high-income countries [2].

Within the occupational groups, prevalence of hypertension tends to vary by region and lifestyle related factors. Studies among Ethiopian civil servants reported rates between 24.5% [8] and 27.3%, while Chinese working adults showed similar figures at 28.1% [15], both lower than the findings of our study. However, the army veterans of the India Gorkha regiment reported higher rate of prevalence of 66.2% [5] and in Bangladesh, government employees demonstrated the prevalence of hypertension as 38.3% [16]. This disparity in the findings may be due to differences in occupational stress, dietary patterns, physical activity, healthcare access, and substance use behaviors across countries. Additionally, methodological differences such as sample size, measurement criteria, or population age distribution could have contributed to variations in reported prevalence. The community-based studies conducted in Kathmandu reported the prevalence of hypertension as 32.5% which is similar to our study’s findings [17].

This study further identified age (30–50 years), work experience, and alcohol consumption as significant factors associated with hypertension. These align with the findings from both national and international studies. The increasing age (age group more than 35 years) and alcohol use were significant in Bangladeshi government employees [17]. However, adjusted odds ratios (AORs), particularly for age groups 30–40 (AOR: 14.4; 95% CI: 1.6–127.7) and 40–50 (AOR: 13.7; 95% CI: 1.04–180.3), have very wide confidence intervals, suggesting a high degree of uncertainty around the estimates. This is likely due to small subgroup sizes or sparse data.

Interestingly, alcohol consumption in our study showed an inverse association (AOR:0.35; 95% CI: 0.17–0.72), potentially reflecting reverse causation, reporting bias, or unmeasured confounding. It is possible that this observed association is influenced by residual confounding or reverse causation, whereby individuals with existing health conditions may reduce or abstain from alcohol use. Moreover, potential underreporting or misclassification of alcohol intake cannot be ruled out. This is a notable limitation of the study and underscores the need for longitudinal research to further explore this relationship.

A cross-sectional study conducted in Kathmandu reported that over three-quarters (78.4%) of participants engaged in sufficient physical activity [17], a figure notably higher than that observed in the present study. This discrepancy could be attributed to the nature of government office work, where employees often spend prolonged hours in sedentary desk jobs, limiting opportunities for regular physical movement and contributing to reduced activity levels.

One of the studies conducted among Bhutanese adults reported that 47% of the study population were found to be currently drinking alcohol [18], which is higher than this study (33.3%). But the findings of this study is higher than that conducted in Kathmandu (27%) [17].Similarly, the current smokers found in this study were higher than that was found by STEPS survey, 2019 (29%) [19].This data showed the increasing trend of risk factors of hypertension among Government employees.

In this study, only 29.7% of participants consumed sufficient number of fruits and vegetables. In contrast, the STEPS survey 2019 reported that 96.7% consumed fewer than five servings of fruits and vegetable per day, indicating insufficient intake of fruit and vegetables consumption [19]. This contrast could be due to the difference in study participants, their education level and purchasing capacity. This study population were employed with regular earning capacity.

According to the European society of cardiology, there is a well-established association between high sodium consumption and hypertension where it clearly highlighted that processed and canned foods often contain high level of sodium which can increase in blood pressure [20]. While in this study, around 11.8% of participants added salt always or often during taking meal, which is higher than that was found in STEPS survey, 2019(5.6%). Additionally, the STEPS survey also reported that 19.5% of study population consumed processed food always or often which is slightly higher than that was found in this study (14.4%) [19].

In conclusion, our findings reveal a concerning elevation in hypertension among government employees which is a notable concern. Interventions tailored to workplace environments such as encompassing routine screenings, healthy diet and physical activity promotion, and alcohol education [21] are critically needed to address this emerging public health challenge.

Limitations of the study

The study adopted a cross-sectional design, which may preclude the establishment of causality with the identified risk factors. Additionally, measurements of fruit and vegetable consumption, salt intake, and behavioral factors such as tobacco use, alcohol consumption, and physical activity were based on self-reports rather than objective measurements, which may introduce reporting and recall biases. However, the researchers made efforts to ensure accurate responses through careful probing.

The response rate of our study was 93%. Since not all approached participants agreed to participate, we have also noted this as a limitation.

Alcohol consumption showed an inverse association with hypertension; however, this should be interpreted with caution due to the cross-sectional design, which limits causal inference. The association may be influenced by residual confounding, reverse causation, or underreporting. The Hosmer-Lemeshow test (p = 0.345) suggested a good model fit, though its accuracy is limited in small samples (n = 195). Despite these constraints, the study provides valuable insights into hypertension and its risk factors among government employees in Nepal.

Conclusion

This study revealed that the prevalence of hypertension among government employees as ranging from 30.8% to 42.0% which is a significant concern. The identified risk factors, including increasing age, work experience and alcohol consumption, call for targeted interventions to mitigate hypertension-related complications within this population. This study provides crucial evidence that can inform the development of evidence-based policies, plans, and programs aimed at reducing modifiable occupational risk factors of hypertension among high-risk groups. The appropriate interventions including lifestyle modification and workplace health programs should be planned and carried out to address the high prevalence of hypertension among government employees.

Supporting information

S1 Table. Behavioral characteristics of the participants and its association with Hypertension.

(DOCX)

pone.0330753.s001.docx (49.1KB, docx)
S1 File. Operational Definitions.

(DOCX)

pone.0330753.s002.docx (15KB, docx)

Acknowledgments

We would like to acknowledge Prof Amod Kumar Poudyal, Mr. Susan Man Shrestha and faculties of Department of Community Medicine, TU, IOM for their support for conducting this study. Similarly, we are grateful to Chiefs of Government Offices within Dipayal Silgadhi Municipality for their support for data collection and also appreciate Mr. Rabindra Bhandari for his guidance in data analysis of this study.

Data Availability

All relevant data are within the manuscriptand its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM. Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–3021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37. doi: 10.1038/s41581-019-0244-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22. doi: 10.1016/S0140-6736(20)30925-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Shrestha DB, Budhathoki P, Sedhai YR, Baniya A, Lamichhane S, Shahi M, et al. Prevalence, awareness, risk factors and control of hypertension in Nepal from 2000 to 2020: A systematic review and meta-analysis. Public Health Pract (Oxf). 2021;2:100119. doi: 10.1016/j.puhip.2021.100119 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sapkota A, Neupane D, Shrestha AD, Adhikari TB, McLachlan CS, Shrestha N. Prevalence and associated factors of hypertension among veterans of the Indian Gorkha regiments living in Pokhara Metropolitan City, Nepal. BMC Health Serv Res. 2021;21:899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.World Health Organization. Hypertension. https://www.who.int/news-room/fact-sheets/detail/hypertension. Accessed 2020 March 20.
  • 7.Bhadoria AS, Kasar PK, Toppo NA, Bhadoria P, Pradhan S, Kabirpanthi V. Prevalence of hypertension and associated cardiovascular risk factors in Central India. J Family Community Med. 2014;21(1):29–38. doi: 10.4103/2230-8229.128775 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Badego B, Yoseph A, Astatkie A. Prevalence and risk factors of hypertension among civil servants in Sidama Zone, south Ethiopia. PLoS One. 2020;15(6):e0234485. doi: 10.1371/journal.pone.0234485 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chataut J, Dahal S, Shrestha A, Bhandari MS. View of prevalence of hypertension and its associated risk factors among bank workers of Kathmandu.
  • 10.Central Bureau of Statistics. National Census 2078 Preliminary Result. https://docs.censusnepal.cbs.gov.np/Documents/National%20Census%202078%20Preliminary%20result.pdf
  • 11.Hasan M, Sutradhar I, Akter T, Das Gupta R, Joshi H, Haider MR, et al. Prevalence and determinants of hypertension among adult population in Nepal: Data from Nepal Demographic and Health Survey 2016. PLoS One. 2018;13(5):e0198028. doi: 10.1371/journal.pone.0198028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Aryal KK, Neupane S, Mehata S, Vaidya A, Singh S, Paulin F. Non communicable diseases risk factors: STEPS survey Nepal. 2013. [PubMed]
  • 13.Centers for Disease Control and Prevention. Measure Your Blood Pressure. https://www.cdc.gov/bloodpressure/measure.htm. 2022. Accessed 2022 November 23.
  • 14.National High Blood Pressure Education Program. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute (US). 2004. https://www.ncbi.nlm.nih.gov/books/NBK9633/ [PubMed] [Google Scholar]
  • 15.Shen Y, Chang C, Zhang J, Jiang Y, Ni B, Wang Y. Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China: a cross-sectional study. Environ Health Prev Med. 2017;22(1):19. doi: 10.1186/s12199-017-0634-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sutradhar P, Kamrul-Hasan AB, Hossain MA, Sarwar-Jahan SM, Rahman MM, Mondol RN, et al. Prevalence and Risk Factors of Hypertension among Government Employees Serving in Rangpur City, Bangladesh. Mymensingh Med J. 2020;29(1):142–8. [PubMed] [Google Scholar]
  • 17.Dhungana RR, Thapa P, Devkota S, Banik PC, Gurung Y, Mumu SJ. Prevalence of cardiovascular disease risk factors: A community-based cross-sectional study in a peri-urban community of Kathmandu, Nepal. Indian Heart J. 2018;70(S):S20-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wangdi K, Jamtsho T. Prevalence and predisposing factors for self-reported hypertension in Bhutanese adults. Nepal J Epidemiol. 2020;10(1):830–40. doi: 10.3126/nje.v10i1.25466 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.World Health Organization. NCD STEPS Survey Nepal 2019. https://www.who.int/docs/default-source/nepal-documents/ncds/ncd-steps-survey-2019-compressed.pdf?sfvrsn=807bc4c6_2
  • 20.Youssef GS. Salt and hypertension: current views. 22.
  • 21.Zhou B, Yang L, Wang J. Workplace-based primary prevention intervention reduces incidence of hypertension: a post hoc analysis of cluster randomized controlled study. BMC Public Health. 2022;22(1):1024. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Chhabi Ranabhat

7 Mar 2025

Dear Dr. Sharma,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Chhabi Lal Ranabhat

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that your Data Availability Statement is currently as follows: [All relevant data are within the manuscript and its Supporting Information files.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The research topic is related to the global burden of hypertension, and in Nepal, specifically rural parts of the country, which is quite interesting. Below are some suggestions.

1) Author has mentioned the title "Far Western Province of Nepal," which implies that the study includes multiple districts. However, based on your methodology, it appears that data was collected only from Doti district and from one municipality. To enhance clarity and accurately reflect the study's scope, I suggest specifying "Doti district of Nepal" in the title instead of "Far Western Province of Nepal." This revision would ensure consistency between the study's title and its actual geographic coverage.

2) The adjusted odds ratio (AOR) for the age group 50–60 years [AOR 11.6, 95% CI (0.73, 6.5)] in lines 40 and 41 does not show statistical significance, as the confidence interval includes 1. It would be more appropriate to clarify this in the results and discussion sections to avoid misinterpretation. Please review and revise accordingly (this issue is similar to line 195).

3) Please consider adding "Nepal" as a keyword in line 50.

4) Specify the exact data collection start and end date ( date /month/year) in line 88 and 89 for clarity.

5) Please provide the response rate in methodology, if not all participants fully participated add in limitation.

6) The authors can merge some variables in the binary logistic regression analysis for clearer interpretation. For example, the age variable could be grouped into two categories: <40 and ≥40 years, and the service type variable could be simplified into two categories: civil service and non-civil service.

7) In Table 3, the authors have added (*) with bold formatting for non-significant p-values (e.g., p = 0.082) I recommend removing the * from non-significant values.

8) please add a footnote below the table to clarify the meaning of * such as:

"P-values less than 0.05 are considered statistically significant and are marked with an *.

9) The p-values presented in Table 3 and 4 appear to be from the multivariate analysis (AOR) only. However, including the p-values from bivariate analysis (COR) alongside them would enhance clarity and provide a better understanding of the selection process for variables in the multivariate model.

10) In line 238 and 239, the authors mentioned that in this study, being male was identified as an associated factor of hypertension (AOR 2.25, 95% CI: 0.7-6.5). However, result is not statistically significant and should not be described as a 'significant risk factor. Similar problems seen in line 253 and 254. Please correct it accordingly.

11) Please add recommendation as well.

12) Please follow proper referencing

Reviewer #2: Dear Authors,

Thank you for submitting the important piece of work, especially carrying out the HTN and its associated factors among the government employees of Doti district in far-western province. The language is okay and written in standard English, except some minor errors such as in Result section (line 179, +- and in table Mean age and sd, and their respective values may be written in different cells.

I propose the following comments and recommend respective corrections with major revisions.

1. Sample size although can not be changed now, pls justify why didn’t taken from doti in far-western province, instead from the national proportion? This is reflected in result also, as 36.4% is observed, which was beyond the expected 20% and its 95% CI. Pls, now, analyse the corrected Margin of error for precision somewhere in result section, interpret and align with discussion.

2. As Hosmer and Lemshow is mentioned as a model fit parameter, it has certain limitations, which you can find in literature. If this is so, how do you interpret such findings of large confidence intervals of AOR (table 3, age group; and similar others in this and subsequent tables), and even shifting OR from risk factor in COR to protective in AOR (table 4, ever drinker; and similar others)? Pls consult the senior statistician with scrutinized observation of data in this case, as further analysis such as interaction and/or both confounding may be the case! Also, keep these parameters in table, and may be more, other comparable parameters, such as AIC, BIC …are needed for further precise/robuster interpretations.

3. Seriously, in page 11 (line 239) you have argued male as a significant factor for HTN, whereas it is clearly found after adjustment non-significant in table 3, as well as from 95% CI. Similar interpretations are also observed in line 254 as in physical activity case!

4. As found discussed with prevalence of HTN among government employees with Bangladesh and other countries, you have compared with 38 and 66 percentages (line 233, discussion), both with higher, but this is quite different, 38 is nearly, but 66 is quite higher! How do you come to the inferences of similar behaviors for these two significant prevalences?

Reviwer

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

PLoS One. 2025 Aug 21;20(8):e0330753. doi: 10.1371/journal.pone.0330753.r002

Author response to Decision Letter 1


12 May 2025

Dear Chhabi Lal Ranabhat,

Academic Editor

PLOS ONE

I am writing in response to the comments provided by the reviewers regarding our manuscript PONE-D-25-05146 entitled "Prevalence of Hypertension and its Associated Factors among Government Employees in Far Western Province of Nepal". We appreciate the time and effort invested by the reviewers and the editorial team in evaluating our work. After careful consideration of the reviewers' comments, we have addressed each point raised and provided our responses below:

Reviewer #1

1. Comment: Title suggests that the study was conducted across the entire Far Western Province, but the data was only collected from Doti district. Please adjust the title to reflect the correct geographic scope.

Response: We agree with the reviewer and have revised the title to "Prevalence of Hypertension and its Associated Factors among Government Employees in Doti District of Nepal" to accurately reflect the study's scope. (Line number 3)

2. Comment: The adjusted odds ratio (AOR) for the 50–60 years age group (AOR 11.6, 95% CI 0.73, 6.5) is not statistically significant. Please revise the results and discussion accordingly.

Response: We have revised both the results and the discussion sections to clarify that this finding is not statistically significant and should not be misinterpreted. (line number 40,41)

3. Comment: Please add "Nepal" as a keyword.

Response: We have added "Nepal" to the list of keywords. (line number 49)

4. Comment: Specify exact data collection start and end dates (date/month/year).

Response: We have updated the specific data collection dates in the revised manuscript as 5th December 2022 to 4th January 2023(line number 125)

5. Comment: Please provide the response rate and add it to the limitations if necessary.

Response: We have added the response rate (93%) to the methodology section. Since not all approached participants agreed to participate, we have also noted this as a limitation. (line number 130,289, 290)

6. Comment: Consider merging variables in the regression analysis for clearer interpretation, such as grouping age categories into <40 and ≥40 years.

Response: We appreciate this suggestion and we agree that merging age categories can sometimes help with clearer interpretation. However, during our regression analysis, we observed that the age groups 30–40 and 40–50 years showed significant associations with hypertension, while the 50–60 years age group did not show a statistically significant association. Therefore, we retained the current categorization to preserve these important distinctions in age-specific risk, which could be masked if broader categories (e.g., <40 and ≥40 years) were used.

7. Comment: Remove the asterisk () for non-significant p-values in Table 3 and Table 4.*

Response: The asterisk (*) has been removed from non-significant p-values, and a footnote has been added to explain that p-values <0.05 are marked with an asterisk.

8. Comment: Please add the p-values from bivariate analysis (COR) alongside those from the multivariate analysis (AOR) in Table 3 and Table 4.

Response: We have included the p-values from both bivariate and multivariate analyses in the revised tables for clarity.

9. Comment: Correct the interpretation of non-significant results, such as male being a significant risk factor for hypertension.

Response: We have revised the discussion to accurately describe that being male was not a statistically significant risk factor for hypertension.

10. Comment: Please add recommendations in the conclusion section.

Response: We have added specific recommendations, including lifestyle interventions and workplace health programs, to address the high prevalence of hypertension among government employees. (line number 299-305)

11. Comment: Please follow proper referencing style.

Response: We have doubled checked and refined all the references to ensure to follow the appropriate referencing style as per PLOS ONE authors guidelines.

Reviewer #2

1. Comment: Justify why the sample size was taken from Doti instead of the national proportion. Also, analyze the corrected margin of error in the results section.

Response: Thank you for your valuable comment. The sample size of 195 was determined using Cochran’s formula for finite population correction, which is appropriate when the target population is relatively small and well-defined.

Although the expected prevalence (p = 0.20) of hypertension was taken from the National Demographic and Health Survey (NDHS) of Nepal, the study population was limited to government employees in Doti district. Therefore, it was both methodologically sound and necessary to use the finite population correction (FPC) based on the actual population of interest — i.e., the total number of government employees in Doti (N = 625).

Margin of Error Clarification:

By applying the finite population correction, the effective margin of error is slightly reduced compared to the initial 5% assumption, leading to more precise estimates.

2. Comment: Review the limitations of the Hosmer-Lemeshow test and interpret large confidence intervals for AOR (age group). Consider including additional model fit parameters, such as AIC or BIC.

Response: Thankyou for your thoughtful comments. We acknowledge and have addressed the concerns regarding model fit evaluation and the interpretation of regression outputs.

Limitations of the Hosmer-Lemeshow Test: While applying the multivariate analysis, the Hosmer and Lemeshow test was performed to test the goodness of fit. The test result (p = 0.345) indicated good model fit. However, we recognize that the Hosmer-Lemeshow test has limitations (line number 291-294). It is sensitive to sample size and can yield misleading results in small samples like ours (n = 195), where it may fail to detect misfit. Furthermore, the grouping of predicted probabilities into deciles is arbitrary and may affect the outcome. Therefore, we agree that relying solely on this test may not provide a full picture of model adequacy.

Interpretation of Wide Confidence Intervals (AORs): As observed in Table 3, some adjusted odds ratios (AORs), particularly for age groups 30–40 (AOR: 14.4; 95% CI: 1.6–127.7) and 40–50 (AOR: 13.7; 95% CI: 1.04–180.3), have very wide confidence intervals, suggesting a high degree of uncertainty around the estimates. This is likely due to small subgroup sizes or sparse data, which can inflate standard errors and widen confidence intervals. Despite statistical significance, these estimates should be interpreted with caution, as the precision is limited. This limitation has now been explicitly mentioned in the discussion section. (line number 243-246)

3. Comment: Correct the misinterpretation of non-significant results for factors such as male gender and physical activity (lines 239 and 254).

Response: We have revised these sections to reflect that the male gender and physical activity were not statistically significant risk factors.

4. Comment: Compare the significantly different hypertension prevalence rates (38% and 66%) between government employees in Nepal and other countries.

Response: We have clarified the comparison between the different prevalence rates and provided additional context regarding the behavioral and lifestyle differences that might account for this disparity.(line number 231-234)

We believe that these revisions have addressed the concerns of both reviewers that helped to improve quality of our paper. We appreciate your valuable feedback and hope that the revised manuscript is now suitable for publication.

Thank you for your time and consideration.

Sincerely,

Sunita Sharma

On behalf of the co-authors

Attachment

Submitted filename: Response to Reviewers.docx

pone.0330753.s003.docx (28.2KB, docx)

Decision Letter 1

Chhabi Ranabhat

26 May 2025

Dear Dr. Sharma,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Dear Authors,

1) Kindly respond to the reviewers' comments and suggestions thoughtfully, considering various perspectives. This should encompass not only Q and A but also,

i) The research question is articulated effectively with supporting evidence.

ii) The most suitable methodology has been employed to derive the results.

iii) Your results are presented clearly, utilizing the best statistical analysis methods, and any discrepancies or errors should be noted, with mandetory consultation and verification from statisticians as needed. If you find that you cannot adequately address the reviewer's comments, please explain why.

iv) Ensure that your revision addresses all comments, is written in flawless English, presents tables and figures on the same pages without fragmentation, and has captions and notes placed appropriately.

2) Please include a few additional sentences in the second paragraph of the 'Introduction' addressing, "Why did you select government employees for the hypertension study, or what makes them at risk?

Good luck!

==============================

Please submit your revised manuscript by Jul 10 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Chhabi Lal Ranabhat

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Partly

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Abstract: line no 7, "which are the leading causes" could be revised into" which remains the leading causes of morbidity and mortality" (or you can revise on your own preferences)

In the methodology sections of the abstract, please add "structured questionnaire adopted from the WHO STEPS survey tool was used" would improve clarity for the reader.

Introduction

ln line 52 , Author has started with Cardiovascular disease (CVD) , it would be more effective to begin with hypertension itself, since it is the central focus of the study and then connect it to its role as a leading modifiable risk factor for CVDs.

Please include a brief rationale at the end of the introduction explaining why government employees in a rural district like Doti were selected as the study population.

Methodology

In line no 93 , You have added the term " Miscellaneous service " please specify what is meant by miscellaneous service ?

Lines 94–95: You have used "were not included." Please revise this to: "Currently employed government staff who were present during the data collection period were included in the study, while those who were on leave or absent were excluded."

Line 134 mentions the Omron automatic BP monitor, but line 141 refers to the random zero sphygmomanometer. These are two different instruments. Please clarify which was actually used.

Results

Line 181: Replace "+_SD" with "± SD."

In the table, please correct the spelling of “Brahmin.”

It is recommended to round the percentages in the education and service type categories so they sum exactly to 100%, for clarity and consistency.

Line 211: The finding that alcohol consumption appears to be a protective factor against hypertension (AOR < 1) is unusual and not supported by most studies. This may be due to a small number of drinkers in the study or information bias. It is recommended that the authors clearly interpret this result in the results section and acknowledge it as a potential limitation in the discussion.

Discussion

In the discussion section, it is suggested to restructure the comparison flow. The authors currently begin by comparing their findings with global and LMIC data, followed by Nepal-specific studies. Please revise the discussion flow to start with Nepalese studies, then South Asian/regional, and finally global data for better context.

Please add a reference to support the conclusion in lines 277–281 regarding interventions and prevention.

Limitation:

Please paraphrase lines 289 and 290 for better readability and flow.

Reviewer #2: Dear Author,

Thank you all for the responses. However, I still did not find any satisfactory responses or corrections for the following comments:

1. Re-analysis with the corrected Margin of error for precision somewhere in result section, interpret and align with discussion.

2. As you have rebutted about the H-L test of goodness of fit, and also about the AIC and BIC as model parameters, how do you assure the fitness?

I hope you will address these issues this time.

With regards,

Reviewer

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Recommendation.docx

pone.0330753.s004.docx (13.3KB, docx)
PLoS One. 2025 Aug 21;20(8):e0330753. doi: 10.1371/journal.pone.0330753.r004

Author response to Decision Letter 2


7 Jul 2025

Respected Chhabi Lal Ranabhat,

Academic Editor

PLOS ONE

I am writing in response to the comments provided by the reviewers regarding our manuscript PONE-D-25-05146R1 entitled "Prevalence of hypertension and its associated factors among government employees in Doti district of Nepal". We appreciate the time and effort invested by the reviewers and the editorial team in evaluating our work. After careful consideration of the reviewers' comments, we have addressed each point raised and provided our responses below:

Reviewer 1

Abstract

Comment: Line 7, “which are the leading causes,” could be revised.

Response: Revised to: “which remain the leading causes of morbidity and mortality globally.” [page no 2, line no26]

Comment: Methodology – Add clarity about the tool used.

Response: Added the sentence: “The structured questionnaire adopted from the WHO STEPS survey tool was used for data collection.” [page no 2, line no 35-36]

Introduction

Comment: Start with hypertension, not CVD, in line 52.

Response: Revised the paragraph to begin with hypertension and subsequently linked it to CVD as a modifiable risk factor as below. [page no 3, line no 53-60]

Hypertension is a leading modifiable risk factor for cardiovascular diseases (CVDs) and premature mortality worldwide. Between 1990 and 2019, global deaths from CVDs increased steadily from 12.1 million to 18.6 million respectively [1]. The prevalence of hypertension among adults is higher in Low Middle Income Countries (LMICs) (31.5%, 1.04 billion people) than in High-Income Countries (28.5%, 349 million people) [2]. The rising prevalence of hypertension, coupled with low medication adherence, poor blood pressure control, and limited knowledge about the condition, presents significant challenges, particularly in low- and middle-income countries (LMICs) [2].

Comment: Add rationale for selecting government employees in rural Doti.

Response: Included rationale at the end of the introduction as below. [page no 3, line no 84-88]

Doti district, one of the underprivileged rural and hilly areas of Nepal has insufficient health data, especially when it comes to non-communicable diseases like hypertension. Studying prevalence of hypertension among government employees in a rural setting like Doti district not only closes a significant evidence gap but also contributes to the development of targeted strategies for the prevention and management of hypertension in underprivileged areas of Nepal.

Methodology

Comment: Line 93 – Clarify "Miscellaneous service."

Response: Revised to specify: “Miscellaneous service includes other gazetted-level government employees falling outside administration or health like audit, foreign affairs, statistics, engineering, agricultural, and other services” [page no 4, line no 102-104]

Comment: Lines 94–95 – Revise inclusion/exclusion phrasing.

Response: Revised to: “Currently employed government staff who were present during the data collection period were included in the study, while those who were on leave or absent were excluded.” [page no 4, line no 104-106]

Comment: Clarify discrepancy between Omron monitor and random zero sphygmomanometer.

Response: Clarified in the manuscript: “Blood pressure was measured using an Omron automatic BP monitor and no random zero sphygmomanometer was used” [page no 6, line no 146-147]

Results

Comment: Line 181 – Replace "+_SD" with "± SD."

Response: Corrected to “± SD.” [page no 7, line no 193]

Comment: Correct spelling of “Brahmin” in the table.

Response: Spelling has been corrected. [page no 8, line no 200]

Comment: Round percentages to sum to 100%.

Response: Percentages have been rounded appropriately to ensure they sum to 100% in the education and service-type categories. [page no 8, line no 200]

Comment: Alcohol consumption appears protective; interpret and note as limitation.

Response: We have noted the unusual finding, and acknowledged it in the discussion as a potential limitation as, [page no 12, line no 263-269] and in the limitations [page no 14, line no 324-326]

Interestingly, alcohol consumption in our study showed an inverse association (AOR :0.35; 95% CI: 0.17-0.72), potentially reflecting reverse causation, reporting bias, or unmeasured confounding. It is possible that this observed association is influenced by residual confounding or reverse causation, whereby individuals with existing health conditions may reduce or abstain from alcohol use. Moreover, potential underreporting or misclassification of alcohol intake cannot be ruled out. This is a notable limitation of the study and underscores the need for longitudinal research to further explore this relationship.

Discussion

Comment: Restructure comparison flow from global to local.

Response: Revised the discussion structure flow from global to local context. [page no 11-13, line no 238-296]

Comment: Add reference to support intervention/prevention statements (lines 277–281).

Response: A supportive interventions are added and proper reference has been added as below [page no 13, line no 296].

Interventions tailored to workplace environments such as encompassing routine screenings, healthy diet and physical activity promotion, and alcohol education [22] are critically needed to address this emerging public health challenge.

Limitation

Comment: Paraphrase lines 289–290 for better clarity.

Response: Revised to: “The study adopted a cross-sectional design, which may preclude the establishment of causality with the identified risk factors. [page no 13 , line no 299-300]

Reviewer 2

Comment 1: Re-analysis with corrected margin of error for precision.

Response: We acknowledge the oversight. The margin of error has been corrected in the statistical analysis. The updated confidence intervals and interpretations are reflected in the results section and aligned appropriately in the discussion as: (page no 8-9, line no 201-210)

The prevalence of hypertension among government employee was found to be 36.4% ± 5.6% (36.4% ± 5.6%) (95% confidence, with finite population correction) as presented in Table 2. The margin of error for sample size (n=195) and total number of government employees in Doti (N = 625) with 95% Confidence Interval has been calculated as follows,

Step 1: Standard Error (without FPC)

SE= √((p(1-p))/n)= √((0.364(1-0.364))/195)= √0.0011872≈0.03447 Step 2: Finite Population Correction (FPC)

FPC= √((N-n)/(N-1))= √((625-195)/624)= √(430/624)= √({0.688} )≈0.8294________________________________________

Step 3: Corrected Margin of Error (MoE)

MoE=z×SE×FPC=1.96×0.03447×0.8294=1.96×0.02859≈0.05604

Margin of Error= 5.6%

Prevalence of hypertension=36.4% ± 5.60% (95% confidence, with finite population correction)

Comment 2: Clarify fitness of model in absence of H-L test, AIC, or BIC.

Response: We appreciate the reviewer’s valuable suggestion regarding additional metrics for model fit assessment. In our analysis, we used the Hosmer–Lemeshow (H–L) test to evaluate the goodness of fit for both models. The first model yielded a p-value of 0.345, and the second model had a p-value of 0.820—both exceeding the conventional threshold of 0.05, indicating acceptable model fit and no significant difference between observed and predicted probabilities.

In addition, we reported the Nagelkerke R² values, which were 0.445 and 0.091, respectively. These values suggest that the explanatory variables in the first model accounted for approximately 45% of the variation in the dependent variable, which represents a moderate explanatory power in epidemiological modeling. While the R² for the second model was relatively low, such values are typical in cross-sectional studies where numerous unmeasured or behavioral factors may influence outcomes.

Regarding AIC or BIC, we acknowledge their usefulness in model comparison and selection. However, as our analysis platform did not provide log-likelihood outputs, calculation of AIC/BIC was not feasible. But we believe that the combination of the Hosmer–Lemeshow test and Nagelkerke R² provides a standard and acceptable evaluation of model fit in cross-sectional logistic regression, particularly within resource-constrained research settings. Further, we have also noted the limitations of these methods in the revised manuscript.

We believe that these revisions have satisfactorily addressed the reviewers' comments and significantly improved the quality of our manuscript. We sincerely appreciate your valuable feedback and hope that the revised manuscript meets the publication standard of your reputed journal. Thank you for your time and consideration.

Sincerely,

Sunita Sharma

On behalf of the co-authors

Attachment

Submitted filename: Response_to_Reviewers_auresp_2.docx

pone.0330753.s005.docx (31.6KB, docx)

Decision Letter 2

Chhabi Ranabhat

6 Aug 2025

Prevalence of hypertension and its associated factors among government employees in Doti district of Nepal

PONE-D-25-05146R2

Dear Dr. Sharma,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Chhabi Lal Ranabhat

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: The authors have addressed all the previous comments and made the necessory revisions accordingly. This study adds important evidence regarding hypertension among government employees and is a valuable contributions.

Reviewer #2: Thank you for addressing the comments; now I am recommending further procedures for acceptance and publication.

Regards

Reviewer

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: Yes:  Chiranjivi Adhikari

**********

Attachment

Submitted filename: comment.docx

pone.0330753.s006.docx (13.6KB, docx)

Acceptance letter

Chhabi Ranabhat

PONE-D-25-05146R2

PLOS ONE

Dear Dr. Sharma,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Chhabi Lal Ranabhat

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Behavioral characteristics of the participants and its association with Hypertension.

    (DOCX)

    pone.0330753.s001.docx (49.1KB, docx)
    S1 File. Operational Definitions.

    (DOCX)

    pone.0330753.s002.docx (15KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0330753.s003.docx (28.2KB, docx)
    Attachment

    Submitted filename: Recommendation.docx

    pone.0330753.s004.docx (13.3KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewers_auresp_2.docx

    pone.0330753.s005.docx (31.6KB, docx)
    Attachment

    Submitted filename: comment.docx

    pone.0330753.s006.docx (13.6KB, docx)

    Data Availability Statement

    All relevant data are within the manuscriptand its Supporting Information files.


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES